The Patent Finder
US

Penetrating Pharmaceutical Foam

US 7,700,076 In force, term unresolved
OverviewFamilyAssignmentsSources & methods

Term ends no later than Sep 18, 2027 · Low confidence

In force on USPTO's status record and by its fee record. A terminal disclaimer on file may shorten this term, possibly to a date already past; its reference document is unresolved, so the date above is an upper bound and no earlier date is guessed.

Filed Aug 20, 2004 as application 10/922,358 · Granted Apr 20, 2010
Base term plus 1425 days of patent term adjustment (USPTO delay)
Today
20 years from filing
2003 2027
Clock starts
Oct 24, 2003
Ends no later than
Sep 18, 2027
Granted
Apr 20, 2010
base term patent term adjustment fee events Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
1,425
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Unresolved
Terminal disclaimer
On file, reference document not resolved, so the date above is an upper bound. We do not guess the cap.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
82
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term runs 1425 days past its 20-year base term on prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. All three maintenance fees are recorded paid; no more fees are due. Confidence: Low. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Oct 24, 2003, when application PCT/IB2003/005527, the earliest non-provisional in its chain, was filed (this one was filed Aug 20, 2004); a parent in its chain could not be resolved (the next row)Oct 24, 2023High confidence
Continuity chainA parent in the chain could not be resolveddated from this application's own claimMedium confidence
Patent term adjustment+1425 days, USPTO patent term adjustment recordSep 18, 2027High confidence
Terminal disclaimer capDisclaimer on file (approved), reference document not resolvedno cap applied, and none guessedMedium confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events3 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderno later than Sep 18, 2027Low confidence

Partial family

Application PCT/IB0300/005527PCT application
no patent term
no patent term
Application PCT/IB2003/005527PCT application
no patent term
no patent term
US 7,820,145In force
Aug 2028
Aug 2028
Application 10/911,367Abandoned
not computed
not computed
US 7,700,076this patent
no later than Sep 2027
no later than Sep 2027
Application 11/041,921Abandoned
not computed
not computed
US 9,668,972Lapsed on the fee record
Jun 2025
Jun 2025
Application 11/078,948Abandoned
not computed
not computed
8 of 82 applications in this family shown, earliest filings first. Partial: 5 of the 82 have no file history here, so a row comes from the patent's own record or names the application alone. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Dec 6, 2004
Reel 15427, frame 918
Tamarkin, Dov; Friedman, Doron; Eini, MeirFoamix, Ltd.Assignment of Assignor's Interest
Jul 30, 2014
Reel 33445, frame 249
Foamix Ltd.Foamix Pharmaceuticals Ltd.Change of Name
Jul 30, 2019
Reel 49912, frame 45
Foamix Pharmaceuticals Ltd.Perceptive Credit Holdings II, LPPatent Security Agreement
Nov 4, 2020
Reel 54306, frame 387
Foamix Pharmaceuticals Ltd.Vyne Pharmaceuticals Ltd.Change of Name
Feb 4, 2021
Reel 55215, frame 298
Vyne Pharmaceuticals Ltd.Vyne Therapeutics Inc.Assignment of Assignor's Interest
Feb 17, 2021
Reel 55326, frame 9
Vyne Therapeutics Inc.Perceptive Credit Holdings II, LPPatent Security Agreement
Sep 20, 2021
Reel 57544, frame 138
Perceptive Credit Holdings II, LPVyne Pharmaceuticals Ltd. (F/K/A Foamix Pharmaceuticals Ltd.)Release of Security Interest
Sep 20, 2021
Reel 57544, frame 708
Perceptive Credit Holdings II, LPVyne Therapeutics Inc. (F/K/A Menlo Therapeutics Inc. and Successor-in-Interest to Vyne Pharmaceuticals Ltd., F/K/A Foamix Pharmaceuticals Ltd.)Release of Security Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited